Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip A Hines

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 4, 2022
Strengthening the Interface of Evidence-Based Decision Making Across European Regulators and Health Technology Assessment BodiesElla Jansen, Philip A Hines, Michael Berntgen, et al.
Nature Reviews. Drug Discovery|November 21, 2022
Artificial intelligence in European medicines regulationPhilip A Hines, Ralf Herold, Luis Pinheiro, et al.
Frontiers in Medicine|December 26, 2022
Health horizons: Future trends and technologies from the European Medicines Agency's horizon scanning collaborationsValentina Vignali, Philip A Hines, Ana Glória Cruz, et al.
Nature Reviews. Drug Discovery|July 30, 2021
Therapeutic genome editing: regulatory horizonsPhilip A Hines, Eleonora Agricola, Jordi Llinares Garcia, et al.
Nature Reviews. Drug Discovery|June 5, 2019
The European Medicines Agency's goals for regulatory science to 2025Philip A Hines, Richard H Guy, Anthony J Humphreys, et al.
Frontiers in Medicine|November 18, 2021
Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines AgencyLaura Patricia Orellana García, Falk Ehmann, Philip A Hines, et al.
British Journal of Clinical Pharmacology|August 20, 2019
Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed modelPhilip A Hines, Richard H Guy, Angela Brand, et al.
Nature Reviews. Drug Discovery|April 3, 2020
A future for regulatory science in the European Union: the European Medicines Agency's strategyPhilip A Hines, Rosanne Janssens, Rosa Gonzalez-Quevedo, et al.
Frontiers in Medicine|October 19, 2020
Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's StrategyPhilip A Hines, Rosa Gonzalez-Quevedo, Apolline I O M Lambert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 4, 2022
Strengthening the Interface of Evidence-Based Decision Making Across European Regulators and Health Technology Assessment BodiesElla Jansen, Philip A Hines, Michael Berntgen, et al.
Nature Reviews. Drug Discovery|November 21, 2022
Artificial intelligence in European medicines regulationPhilip A Hines, Ralf Herold, Luis Pinheiro, et al.
Frontiers in Medicine|December 26, 2022
Health horizons: Future trends and technologies from the European Medicines Agency's horizon scanning collaborationsValentina Vignali, Philip A Hines, Ana Glória Cruz, et al.
Nature Reviews. Drug Discovery|July 30, 2021
Therapeutic genome editing: regulatory horizonsPhilip A Hines, Eleonora Agricola, Jordi Llinares Garcia, et al.
Nature Reviews. Drug Discovery|June 5, 2019
The European Medicines Agency's goals for regulatory science to 2025Philip A Hines, Richard H Guy, Anthony J Humphreys, et al.
Frontiers in Medicine|November 18, 2021
Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines AgencyLaura Patricia Orellana García, Falk Ehmann, Philip A Hines, et al.
British Journal of Clinical Pharmacology|August 20, 2019
Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed modelPhilip A Hines, Richard H Guy, Angela Brand, et al.
Nature Reviews. Drug Discovery|April 3, 2020
A future for regulatory science in the European Union: the European Medicines Agency's strategyPhilip A Hines, Rosanne Janssens, Rosa Gonzalez-Quevedo, et al.
Frontiers in Medicine|October 19, 2020
Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's StrategyPhilip A Hines, Rosa Gonzalez-Quevedo, Apolline I O M Lambert, et al.
Pageof 1